Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-067130
Filing Date
2025-07-11
Accepted
2025-07-11 06:49:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2520348-1_424b5.htm 424B5 863884
2 GRAPHIC lg_milestonepharma-4c.jpg GRAPHIC 15063
  Complete submission text file 0001104659-25-067130.txt   885829
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-283162 | Film No.: 251117483
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)